A virus is an acellular pathogen dependent on host materials to replicate. HIV is an enveloped retrovirus that can cause serious illness in infected individuals, leading to acquired immune deficiency syndrome (AIDS) if left untreated. In the United States, HIV presents a public health challenge, with an estimated prevalence of 1.2 million individuals infected by AIDs in the population. Health science policies are strategies that can be implemented into healthcare to prevent pathogen transmission and reduce disease burden. Health policies aimed at reducing the transmission of HIV vary across states, with some states enacting policies and legislation to expand pharmacists’ scope of practice. These policies aim to increase patient accessibility to HIV PrEP, a pharmacologic form of HIV prophylaxis used to prevent HIV transmission. Further analysis and research of these policies are necessary to optimize the safety and effectiveness of pharmacist-led HIV PrEP dissemination.
No takes yet. Share an insight, caveat, or question.
Bodine et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: